MedPath

ECI Pharmaceuticals LLC

ECI Pharmaceuticals LLC logo
🇺🇸United States
Ownership
Private
Established
2010-01-01
Employees
11
Market Cap
-
Website
http://ecipharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

FDA:13

Drug Approvals

Phenazopyridine Hydrochloride

Approval Date
Mar 22, 2023
FDA

Tadalafil

Approval Date
Mar 22, 2023
FDA

Phenobarbital

Approval Date
Jan 4, 2023
FDA

Salsalate

Approval Date
Aug 26, 2022
FDA

Sodium Polystyrene Sulfonate

Approval Date
Mar 3, 2022
FDA

Phenobarbital

Approval Date
Mar 3, 2022
FDA

ibuprofen

Approval Date
Jan 15, 2022
FDA

Folic Acid

Approval Date
Apr 8, 2021
FDA

Phenazopyridine Hydrochloride

Approval Date
Dec 27, 2020
FDA

Methimazole

Approval Date
Dec 27, 2020
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.